FDA Inspection
Lifepharma FZELifepharma FZE – FDA Inspection, Aug 4, 2017
Record Details
This FDA Inspection record concerns Lifepharma FZE, with an inspection on August 4, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 5945620b-3129-4277-8660-956bfbe7171b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1020298
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lifepharma FZE
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Lifepharma FZE
- FDA Inspection 1191272 - 2022-11-24
- FDA Inspection 1070936 - 2018-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.